- Home
- BNBX vs BBLG Comparison
BNBX vs BBLG Comparison
Compare BNBX & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNBX | BBLG |
|---|---|---|
| Founded | 1983 | 2004 |
| Country | United States | United States |
| Employees | 26 | 2 |
| Industry | Other Consumer Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BNBX | BBLG |
|---|---|---|
| Price | $0.37 | $1.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 95.2K | 38.9K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $253.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $1.05 |
| 52 Week High | $6.17 | $4.13 |
Technical Indicators
Market Signals| Indicator | BNBX | BBLG |
|---|---|---|
| Relative Strength Index (RSI) | 38.58 | 56.02 |
| Support Level | $0.35 | $1.39 |
| Resistance Level | $0.85 | $1.54 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 27.46 | 55.00 |
Price Performance
Historical ComparisonAbout BNBX Applied DNA Sciences Inc.
BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.
About BBLG Bone Biologics Corp
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.